Health Canada approves NEUPRO® (rotigotine) patch for treatment of … – Canada NewsWire (press release)

by admin on April 5, 2013

Health Canada approves NEUPRO® (rotigotine) patch for treatment of
Canada NewsWire (press release)
OAKVILLE, ON, April 2, 2013 /CNW/ – UCB Canada Inc. announced today that Health Canada has approved NEUPRO® (rotigotine), the first and only non-ergolinic dopamine agonist available in a patch, to treat the signs and symptoms of idiopathic

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: